ProPhase Labs Q1 2024 GAAP EPS $(0.07) Beats $(0.18) Estimate, Sales $3.634M Miss $9.860M Estimate
Author: Benzinga Newsdesk | May 09, 2024 08:02am
ProPhase Labs (NASDAQ:
PRPH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.18) by 61.11 percent. The company reported quarterly sales of $3.634 million which missed the analyst consensus estimate of $9.860 million by 63.14 percent. This is a 81.17 percent decrease over sales of $19.303 million the same period last year.
Posted In: PRPH